2014
DOI: 10.1111/jcpe.12282
|View full text |Cite
|
Sign up to set email alerts
|

Metronidazole and amoxicillin as adjuncts to scaling and root planing for the treatment of type 2 diabetic subjects with periodontitis: 1‐year outcomes of a randomized placebo‐controlled clinical trial

Abstract: The adjunctive use of MTZ+AMX significantly improved the clinical and microbiological outcomes of SRP in the treatment of type 2 diabetic subjects with ChP.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
134
0
2

Year Published

2015
2015
2023
2023

Publication Types

Select...
6
1

Relationship

2
5

Authors

Journals

citations
Cited by 72 publications
(137 citation statements)
references
References 39 publications
1
134
0
2
Order By: Relevance
“…The study investigators reported on 6 major groups of antimicrobials: amoxicillin and metronidazole combination therapy, 18,44,45,47,50,55,60 metronidazole, 39,52,61 erythromycin analogues (azithromycin 39,46,49,51,[56][57][58][59] and clarithromycin 53 ), moxifloxacin 48 (a fourth-generation fluoroquinolone antibacterial agent), and others (for example, tetracycline 20,43,54 and doxycycline 22,48,62 as the antimicrobial dose of doxycycline, not to be confused with SDD, which is covered in a separate section). The variety of dosing regimens used for each systemic antimicrobial drug is described elsewhere.…”
Section: Moderatementioning
confidence: 99%
See 1 more Smart Citation
“…The study investigators reported on 6 major groups of antimicrobials: amoxicillin and metronidazole combination therapy, 18,44,45,47,50,55,60 metronidazole, 39,52,61 erythromycin analogues (azithromycin 39,46,49,51,[56][57][58][59] and clarithromycin 53 ), moxifloxacin 48 (a fourth-generation fluoroquinolone antibacterial agent), and others (for example, tetracycline 20,43,54 and doxycycline 22,48,62 as the antimicrobial dose of doxycycline, not to be confused with SDD, which is covered in a separate section). The variety of dosing regimens used for each systemic antimicrobial drug is described elsewhere.…”
Section: Moderatementioning
confidence: 99%
“…Compared with SRP alone, SRP plus systemic antimicrobials resulted in a 0.35-mm mean gain in CAL (95% CI, 0.20-0.51) ( Figure 5). 18,20,22,39,[43][44][45][46][47][48][49][50][51][52][53][54][55][56][57][58][59][60][61][62] We judged the overall level of certainty in the evidence to be moderate on the basis of the evidence profile in Table 3.…”
Section: Moderatementioning
confidence: 99%
“…The patients treated with antibiotics had greater reduction in three high-risk pathogens: Tf , Td , Pg . Again, this is a very small study, and results need to be interpreted with caution 35. Issues with management extend beyond simply the initial therapy of high-risk pathogens.…”
Section: Discussionmentioning
confidence: 87%
“…Again, this is a very small study, and results need to be interpreted with caution. 35 Issues with management extend beyond simply the initial therapy of high-risk pathogens. What is the most effective manner in which to maintain periodontal health?…”
Section: Discussionmentioning
confidence: 99%
“…Few studies reported the effects of AMX and MTZ on response of inflammatory biomarker (Almaghlouth, Cionca, Cancela, Decaillet, Courvoisier, Giannopoulou, & Mombelli, 2014, Giannopoulou et al, 2016). Furthermore, the effect of the combination of AMX and MTZ on diabetes has also been reported (Miranda et al, 2014). However, most of these studies focused on the effects of one or two antibiotics, and these have not compared the effectiveness with other antibiotics.…”
Section: Introductionmentioning
confidence: 91%